RSS-Feed abonnieren
DOI: 10.1055/s-0028-1098914
© Georg Thieme Verlag Stuttgart ˙ New York
Erste Ergebnisse der PET / CT-gesteuerten sekundären Lymphknotenchirurgie bei Patienten mit PSA-Anstieg nach radikaler Prostatektomie
First Results of PET / CT-Guided Secondary Lymph Node Surgery on Patients with a PSA Relapse after Radical ProstatectomyPublikationsverlauf
Publikationsdatum:
16. Juni 2009 (online)
![](https://www.thieme-connect.de/media/uro/200905/lookinside/thumbnails/10.1055-s-0028-1098914-1.jpg)
Zusammenfassung
Fragestellung: Computer- und Magnetresonanztomografie sind zur frühen Detektion von kleinen Lymphknoten(LK)-Rezidiven beim Prostatakarzinom ungeeignet. Die neueste PET / CT (11C-, 18F-Cholin)-Technik erfasst bereits kleinere Läsionen (≥ 5 mm) und ermöglicht die topografische Zuordnung. Wir überprüften positive 11C-Cholin-PET / CT-LK-Befunde bei PSA-Anstieg nach radikaler Prostatektomie (RPE) histologisch und dokumentierten den PSA-Verlauf.Material und Methoden: Untersucht wurden 8 Patienten mit PSA-Rezidiv nach RPE und im 11C-Cholin-PET / CT diagnostizierten LK-Metastasen ohne Lokalrezidiv oder Fernmetastasen. Die im PET-CT metastasensuspekten und benachbarte LK wurden offen operativ entfernt. Histologischer und PET / CT-Befund wurden verglichen und der postoperative PSA-Verlauf erfasst. Ergebnisse: Von den im PET / CT metastasensuspekten LK (11) wurden 9 histologisch bestätigt. Alle zusätzlich entfernten LK (12) waren richtig negativ. Die LK-Metastasen lagen größtenteils (7 von 9) im Iliaca-interna-Gebiet und pararektal. 6 von 7 Patienten mit histologischem Metastasennachweis zeigten ein PSA-Ansprechen. Drei von 6 Patienten mit solitärer Metastase hatten eine komplette PSA-Remission (< 0,01 ng / ml) ohne adjuvante Therapie (maximale Nachbeobachtung 28 Monate). Bei einem Patienten mit inkompletter Remission wurde später ein Lokalrezidiv nachgewiesen.Schlussfolgerung: Die 11C-Cholin-PET / CT konnte hier die LK-Metastasen mit hoher Spezifität detektieren. Diese liegen häufig außerhalb des Standard-LA-Gebietes, wo sie primär allenfalls eine ausgedehnte bzw. Sentinel-LA erfassen kann. Da bei 3 Patienten mit solitärer LK-Metastase durch die sekundäre Metastasenchirurgie eine komplette bleibende PSA-Remission (< 0,01 ng / ml) ohne adjuvante Therapie erreicht wurde, scheint es so, dass zumindest dieses spezielle Patientenkollektiv von der operativen Behandlung profitiert hat. Ob einzelne Patienten operativ geheilt werden können, wird erst der Langzeitverlauf zeigen. Grundvoraussetzung dafür ist eine optimale Bildgebung und Erfahrung in der LK-Chirurgie.
Abstract
Purpose: CT and MRT are not applicable for the early detection of lymph node (LN) recurrence in prostate cancer. The PET / CT (11C-, 18F-choline) technique can detect lesions ≥ 5 mm and allows their topographic localisation. We have analysed positive 11C-choline PET / CT LN findings in the case of a PSA increase after radical prostatectomy (RPE) histologicaly and documented the developing of PSA. Materials and Methods: 8 patients with PSA relapse after RPE and lymphadenedtomy (LA) were diagnosed as having LNM by means of 11C-choline PET / CT. Using PET / CT, metastasis suspicious and nearby LN were openly dissected. Histological and PET / CT results were compared and the postoperative PSA-development was examined. Results: Of the metastasis suspicious LN (11) 9 were histologically reconfirmed. All additionally removed LN (12) were correct negative. LNM were mostly (7 of 9) located in the iliaca interna area and pararectal. 6 of 7 patients with histological metastasis detection showed a PSA response. 3 of 6 patients with single metastasis had complete PSA remission (< 0.01 ng / ml, maximum follow-up: 28 months) without adjuvant therapy. Conclusions: 11 C-choline PET / CT could detect LNM with high specificity in our collective. These often lie beyond standard LA area, where they were primarily only resected by use of extended or sentinel LA. Because 3 patients with single LNM reached a complete PSA remission (< 0.01 ng / ml) without adjuvant therapy, the selected collective seems to benefit from secondary LN surgery. Whether or not individual patients can be cured by this surgery has to be demonstrated in a longitudinal study. However, an optimal imaging and experience in LN surgery have to be assured.
Schlüsselwörter
Prostatakarzinom - 11C-Cholin PET / CT - Lymphknotenrezidiv - biochemisches Rezidiv - sekundäre Lymphknotenchirurgie
Key words
prostate cancer - 11C-choline PET / CT - lymph node recurrence - prostate-specific antigen relapse - secondary lymph node surgery
Literatur
- 1 Aus G., Abbou C. C., Bolla M. et al. EAU guidelines on prostate cancer. Eur Urol. 2005; 48 546-551
- 2 Bader P., Burkhard F. C., Markwalder R. et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol. 2002; 168 514-518
- 3 Bader P., Burkhard F. C., Markwalder R. et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol. 2003; 169 849-854
- 4 Catalona W. J., Miller D. R., Kavoussi L. R.. Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol. 1988; 140 540-543
- 5 Daneshmand S., Quek M. L., Stein J. P. et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol. 2004; 172 2252-2255
- 6 de Jong I. J., Pruim J., Elsinga P. H. et al. Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol. 2002; 42 18-23
- 7 de Jong I. J., Pruim J., Elsinga P. H. et al. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med. 2003; 44 331-335
- 8 de Jong I. J., Pruim J., Elsinga P. H. et al. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol. 2003; 44 32-38
- 9 Hacker A., Jeschke S., Leeb K. et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol. 2006; 176 2014-2018
- 10 Hara T., Kosaka N., Kishi H.. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998; 39 990-995
- 11 Harisinghani M. G., Barentsz J., Hahn P. F. et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003; 348 2491-2499
- 12 Heesakkers R. A., Hovels A. M., Jager G. J. et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol. 2008; 9 850-856
- 13 Heidenreich A., Varga Z., Von Knobloch R.. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol. 2002; 167 1681-1686
- 14 Heinisch M., Dirisamer A., Loidl W. et al. Positron emission tomography / computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng / ml?. Mol Imaging Biol. 2006; 8 43-48
- 15 Hovels A. M., Heesakkers R. A., Adang E. M. et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008; 63 387-395
- 16 Husarik D. B., Miralbell R., Dubs M. et al. Evaluation of [(18)F]-choline PET / CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2008; 35 253-263
- 17 Kitzbichler G., Rotter R., Höltl L. et al. Detektion einer singulären Metastase eines Prostatakarzinoms nach RPE mittels PET-CT und PSA-Normalisierung nach Resektion. J Urol Urogynäkol. 2008; 15 ( (Sonderheft 2)) 31
- 18 Kotzerke J., Volkmer B. G., Glatting G. et al. Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin. 2003; 42 25-30
- 19 Oyama N., Miller T. R., Dehdashti F. et al. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med. 2003; 44 549-555
- 20 Partin A. W., Oesterling J. E.. The clinical usefulness of prostate specific antigen: update 1994. J Urol. 1994; 152 1358-1368
- 21 Picchio M., Messa C., Landoni C. et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol. 2003; 169 1337-1340
- 22 Rinnab L., Mottaghy F. M., Blumstein N. M. et al. Evaluation of [11C]-choline positron-emission / computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. BJU Int. 2007; 100 786-793
- 23 Scattoni V., Roscigno M., Raber M. et al. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol. 2003; 44 407-414
- 24 Scattoni V., Montorsi F., Picchio M. et al. Diagnosis of local recurrence after radical prostatectomy. BJU Int. 2004; 93 680-688
- 25 Scattoni V., Picchio M., Suardi N. et al. Detection of lymph-node metastases with integrated [11C]choline PET / CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol. 2007; 52 423-429
- 26 Schilling D., Schlemmer H. P., Wagner P. H. et al. Histological verification of 11C-choline-positron emission / computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int. 2008; 102 446-451
- 27 Tiguert R., Gheiler E. L., Tefilli M. V. et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology. 1999; 53 367-371
- 28 Wawroschek F., Vogt H., Weckermann D. et al. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol. 2001; 166 1715-1719
- 29 Weckermann D., Goppelt M., Dorn R. et al. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or = 10 ng / mL and biopsy Gleason score of < or = 6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int. 2006; 97 1173-1178
- 30 Weckermann D., Dorn R., Holl G. et al. Limitations of radioguided surgery in high-hisk prostate cancer. Eur Urol. 2007; 51 1549-1558
Dr. A. Winter
Klinik für Urologie und Kinderurologie · Klinikum Oldenburg
Rahel-Straus-Str. 10
26133 Oldenburg
Telefon: 04 41 / 4 03 23 02
eMail: winter.alexander@klinikum-oldenburg.de